Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Sell
50
GROV Quote, Financials, Valuation and Earnings
Last price:
$1.56
Seasonality move
:
5.82%
Day range:
$1.46 - $1.59
52-week range:
$1.19 - $1.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.28x
P/B ratio:
42.98x
Volume:
162.5K
Avg. volume:
86.9K
1-year change:
-17.99%
Market cap:
$68.3M
Revenue:
$203.4M
EPS (TTM):
-$0.76
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GROV
Grove Collaborative Holdings
|
$48.8M | -$0.15 | -12.21% | -60% | $2.50 |
|
EWCZ
European Wax Center
|
$52.2M | $0.06 | -3.47% | -6.25% | $6.31 |
|
HIMS
Hims & Hers Health
|
$470.5M | $0.22 | 92.4% | 312.9% | $44.16 |
|
KVUE
Kenvue
|
$3.8B | $0.26 | -5.39% | 54.63% | $24.00 |
|
SKIN
The Beauty Health
|
$77.4M | -$0.09 | -21.04% | -30% | $1.58 |
|
WALD
Waldencast PLC
|
$70.7M | -$0.06 | -- | -- | $5.38 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GROV
Grove Collaborative Holdings
|
$1.55 | $2.50 | $68.3M | -- | $0.00 | 0% | 0.28x |
|
EWCZ
European Wax Center
|
$4.00 | $6.31 | $173.4M | 17.86x | $0.00 | 0% | 0.86x |
|
HIMS
Hims & Hers Health
|
$34.75 | $44.16 | $7.7B | 64.35x | $0.00 | 0% | 5.57x |
|
KVUE
Kenvue
|
$23.31 | $24.00 | $44.6B | 43.98x | $0.21 | 3.5% | 2.90x |
|
SKIN
The Beauty Health
|
$1.31 | $1.58 | $164.1M | -- | $0.00 | 0% | 0.54x |
|
WALD
Waldencast PLC
|
$3.11 | $5.38 | $382.1M | -- | $0.00 | 0% | 1.24x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GROV
Grove Collaborative Holdings
|
31.62% | 1.822 | 9.37% | 0.73x |
|
EWCZ
European Wax Center
|
85.49% | -1.418 | 115.69% | 1.58x |
|
HIMS
Hims & Hers Health
|
-- | 7.338 | -- | 1.38x |
|
KVUE
Kenvue
|
46.77% | 1.501 | 20.79% | 0.65x |
|
SKIN
The Beauty Health
|
91.42% | 0.014 | 278% | 5.85x |
|
WALD
Waldencast PLC
|
20.1% | -0.007 | 29.67% | 0.53x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GROV
Grove Collaborative Holdings
|
$25.9M | -$8.3M | -39.61% | -154.22% | -22.3% | -$95K |
|
EWCZ
European Wax Center
|
$37M | $12.8M | 2.18% | 9.76% | 16.01% | $16.3M |
|
HIMS
Hims & Hers Health
|
$369.5M | $18.6M | 32.03% | 32.03% | 3.87% | $59.5M |
|
KVUE
Kenvue
|
$2.1B | $557M | 5.43% | 9.84% | 13.49% | $661M |
|
SKIN
The Beauty Health
|
$52.3M | -$7.2M | -4.33% | -47.95% | -11.09% | $15.6M |
|
WALD
Waldencast PLC
|
-- | -- | -4.62% | -5.64% | -- | -- |
Grove Collaborative Holdings vs. Competitors
-
Which has Higher Returns GROV or EWCZ?
European Wax Center has a net margin of -25.53% compared to Grove Collaborative Holdings's net margin of 3.96%. Grove Collaborative Holdings's return on equity of -154.22% beat European Wax Center's return on equity of 9.76%.
Company Gross Margin Earnings Per Share Invested Capital GROVGrove Collaborative Holdings52.41% -$0.34 $23.7M EWCZEuropean Wax Center74.34% $0.04 $468.8M -
What do Analysts Say About GROV or EWCZ?
Grove Collaborative Holdings has a consensus price target of $2.50, signalling upside risk potential of 61.29%. On the other hand European Wax Center has an analysts' consensus of $6.31 which suggests that it could grow by 57.81%. Given that Grove Collaborative Holdings has higher upside potential than European Wax Center, analysts believe Grove Collaborative Holdings is more attractive than European Wax Center.
Company Buy Ratings Hold Ratings Sell Ratings GROVGrove Collaborative Holdings2 0 0 EWCZEuropean Wax Center3 5 1 -
Is GROV or EWCZ More Risky?
Grove Collaborative Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GROV or EWCZ?
Grove Collaborative Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Grove Collaborative Holdings pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GROV or EWCZ?
Grove Collaborative Holdings quarterly revenues are $49.5M, which are smaller than European Wax Center quarterly revenues of $49.7M. Grove Collaborative Holdings's net income of -$12.6M is lower than European Wax Center's net income of $2M. Notably, Grove Collaborative Holdings's price-to-earnings ratio is -- while European Wax Center's PE ratio is 17.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings is 0.28x versus 0.86x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GROVGrove Collaborative Holdings0.28x -- $49.5M -$12.6M EWCZEuropean Wax Center0.86x 17.86x $49.7M $2M
-
Which has Higher Returns GROV or HIMS?
Hims & Hers Health has a net margin of -25.53% compared to Grove Collaborative Holdings's net margin of 5.41%. Grove Collaborative Holdings's return on equity of -154.22% beat Hims & Hers Health's return on equity of 32.03%.
Company Gross Margin Earnings Per Share Invested Capital GROVGrove Collaborative Holdings52.41% -$0.34 $23.7M HIMSHims & Hers Health76.81% $0.11 $476.7M -
What do Analysts Say About GROV or HIMS?
Grove Collaborative Holdings has a consensus price target of $2.50, signalling upside risk potential of 61.29%. On the other hand Hims & Hers Health has an analysts' consensus of $44.16 which suggests that it could grow by 27.09%. Given that Grove Collaborative Holdings has higher upside potential than Hims & Hers Health, analysts believe Grove Collaborative Holdings is more attractive than Hims & Hers Health.
Company Buy Ratings Hold Ratings Sell Ratings GROVGrove Collaborative Holdings2 0 0 HIMSHims & Hers Health4 7 1 -
Is GROV or HIMS More Risky?
Grove Collaborative Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.368, suggesting its more volatile than the S&P 500 by 36.817%.
-
Which is a Better Dividend Stock GROV or HIMS?
Grove Collaborative Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Grove Collaborative Holdings pays -- of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GROV or HIMS?
Grove Collaborative Holdings quarterly revenues are $49.5M, which are smaller than Hims & Hers Health quarterly revenues of $481.1M. Grove Collaborative Holdings's net income of -$12.6M is lower than Hims & Hers Health's net income of $26M. Notably, Grove Collaborative Holdings's price-to-earnings ratio is -- while Hims & Hers Health's PE ratio is 64.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings is 0.28x versus 5.57x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GROVGrove Collaborative Holdings0.28x -- $49.5M -$12.6M HIMSHims & Hers Health5.57x 64.35x $481.1M $26M
-
Which has Higher Returns GROV or KVUE?
Kenvue has a net margin of -25.53% compared to Grove Collaborative Holdings's net margin of 8%. Grove Collaborative Holdings's return on equity of -154.22% beat Kenvue's return on equity of 9.84%.
Company Gross Margin Earnings Per Share Invested Capital GROVGrove Collaborative Holdings52.41% -$0.34 $23.7M KVUEKenvue56.53% $0.15 $18.2B -
What do Analysts Say About GROV or KVUE?
Grove Collaborative Holdings has a consensus price target of $2.50, signalling upside risk potential of 61.29%. On the other hand Kenvue has an analysts' consensus of $24.00 which suggests that it could grow by 2.97%. Given that Grove Collaborative Holdings has higher upside potential than Kenvue, analysts believe Grove Collaborative Holdings is more attractive than Kenvue.
Company Buy Ratings Hold Ratings Sell Ratings GROVGrove Collaborative Holdings2 0 0 KVUEKenvue3 12 0 -
Is GROV or KVUE More Risky?
Grove Collaborative Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kenvue has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GROV or KVUE?
Grove Collaborative Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue offers a yield of 3.5% to investors and pays a quarterly dividend of $0.21 per share. Grove Collaborative Holdings pays -- of its earnings as a dividend. Kenvue pays out 150.68% of its earnings as a dividend.
-
Which has Better Financial Ratios GROV or KVUE?
Grove Collaborative Holdings quarterly revenues are $49.5M, which are smaller than Kenvue quarterly revenues of $3.7B. Grove Collaborative Holdings's net income of -$12.6M is lower than Kenvue's net income of $293M. Notably, Grove Collaborative Holdings's price-to-earnings ratio is -- while Kenvue's PE ratio is 43.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings is 0.28x versus 2.90x for Kenvue. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GROVGrove Collaborative Holdings0.28x -- $49.5M -$12.6M KVUEKenvue2.90x 43.98x $3.7B $293M
-
Which has Higher Returns GROV or SKIN?
The Beauty Health has a net margin of -25.53% compared to Grove Collaborative Holdings's net margin of -12.37%. Grove Collaborative Holdings's return on equity of -154.22% beat The Beauty Health's return on equity of -47.95%.
Company Gross Margin Earnings Per Share Invested Capital GROVGrove Collaborative Holdings52.41% -$0.34 $23.7M SKINThe Beauty Health62.69% -$0.08 $604M -
What do Analysts Say About GROV or SKIN?
Grove Collaborative Holdings has a consensus price target of $2.50, signalling upside risk potential of 61.29%. On the other hand The Beauty Health has an analysts' consensus of $1.58 which suggests that it could grow by 20.23%. Given that Grove Collaborative Holdings has higher upside potential than The Beauty Health, analysts believe Grove Collaborative Holdings is more attractive than The Beauty Health.
Company Buy Ratings Hold Ratings Sell Ratings GROVGrove Collaborative Holdings2 0 0 SKINThe Beauty Health0 7 0 -
Is GROV or SKIN More Risky?
Grove Collaborative Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GROV or SKIN?
Grove Collaborative Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Grove Collaborative Holdings pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GROV or SKIN?
Grove Collaborative Holdings quarterly revenues are $49.5M, which are smaller than The Beauty Health quarterly revenues of $83.5M. Grove Collaborative Holdings's net income of -$12.6M is lower than The Beauty Health's net income of -$10.3M. Notably, Grove Collaborative Holdings's price-to-earnings ratio is -- while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings is 0.28x versus 0.54x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GROVGrove Collaborative Holdings0.28x -- $49.5M -$12.6M SKINThe Beauty Health0.54x -- $83.5M -$10.3M
-
Which has Higher Returns GROV or WALD?
Waldencast PLC has a net margin of -25.53% compared to Grove Collaborative Holdings's net margin of --. Grove Collaborative Holdings's return on equity of -154.22% beat Waldencast PLC's return on equity of -5.64%.
Company Gross Margin Earnings Per Share Invested Capital GROVGrove Collaborative Holdings52.41% -$0.34 $23.7M WALDWaldencast PLC-- -- $896.6M -
What do Analysts Say About GROV or WALD?
Grove Collaborative Holdings has a consensus price target of $2.50, signalling upside risk potential of 61.29%. On the other hand Waldencast PLC has an analysts' consensus of $5.38 which suggests that it could grow by 72.99%. Given that Waldencast PLC has higher upside potential than Grove Collaborative Holdings, analysts believe Waldencast PLC is more attractive than Grove Collaborative Holdings.
Company Buy Ratings Hold Ratings Sell Ratings GROVGrove Collaborative Holdings2 0 0 WALDWaldencast PLC4 2 0 -
Is GROV or WALD More Risky?
Grove Collaborative Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Waldencast PLC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GROV or WALD?
Grove Collaborative Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Grove Collaborative Holdings pays -- of its earnings as a dividend. Waldencast PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GROV or WALD?
Grove Collaborative Holdings quarterly revenues are $49.5M, which are larger than Waldencast PLC quarterly revenues of --. Grove Collaborative Holdings's net income of -$12.6M is higher than Waldencast PLC's net income of --. Notably, Grove Collaborative Holdings's price-to-earnings ratio is -- while Waldencast PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Grove Collaborative Holdings is 0.28x versus 1.24x for Waldencast PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GROVGrove Collaborative Holdings0.28x -- $49.5M -$12.6M WALDWaldencast PLC1.24x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
